Molbio Diagnostics IPO: Price Band ₹768-₹807, Opens Aug 10
Source: Mint Markets
Arth Insight · What this means for your wallet
- Molbio Diagnostics IPO price band is ₹768-₹807 per share.
- The IPO subscription opens on August 10 and closes on August 12.
- The minimum investment for retail investors is ₹13,824 for 18 shares.
Wealth-Impact Simulator
See what a one-time investment could grow to.
Indicative estimate for education only — not investment advice.
Explore investmentsMolbio Diagnostics has announced its Initial Public Offering (IPO) with a price band set between ₹768 and ₹807 per share. The subscription period will be open from August 10 to August 12.
- ▸Molbio Diagnostics IPO price band is ₹768-₹807 per share.
- ▸The IPO subscription opens on August 10 and closes on August 12.
- ▸The minimum investment for retail investors is ₹13,824 for 18 shares.
- ✓Molbio Diagnostics IPO price band is ₹768-₹807 per share.
- ✓The IPO subscription opens on August 10 and closes on August 12.
- ✓The minimum investment for retail investors is ₹13,824 for 18 shares.
Molbio Diagnostics Limited has officially set the price band for its upcoming Initial Public Offering (IPO), inviting investors to subscribe between ₹768 and ₹807 per equity share. The subscription window for the public issue will open on August 10 and close on August 12, 2023. Anchor investors will have the opportunity to place their bids on August 7.
The minimum lot size for retail investors has been fixed at 18 shares, meaning the minimum investment would be ₹13,824 (18 shares x ₹768). While the total issue size is yet to be disclosed, the price band provides a clear indication of the valuation the company is seeking from the market.
Molbio Diagnostics is a significant player in the diagnostics sector, known for its innovative point-of-care testing solutions. The company's focus on developing and manufacturing molecular diagnostic instruments and reagents has positioned it as a key contributor to healthcare accessibility, particularly in remote areas.
This IPO presents an opportunity for retail investors to participate in the growth story of a company operating in the rapidly expanding healthcare and diagnostics market in India. Investors are advised to carefully review the company's financials, future prospects, and the Red Herring Prospectus (RHP) before making any investment decisions.
This information is for educational purposes only and does not constitute investment advice.
Community Pulse · This story
How readers rate the outlook after reading this article. Anonymous · one vote per reader · updates live.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.
Frequently Asked Questions
What is the price band for the Molbio Diagnostics IPO?
The price band for the Molbio Diagnostics IPO is set between ₹768 and ₹807 per equity share.
When will the Molbio Diagnostics IPO open and close?
The IPO subscription will open on August 10, 2023, and will close on August 12, 2023.
What is the minimum investment required for retail investors?
The minimum lot size is 18 shares, making the minimum investment ₹13,824 (18 shares x ₹768).
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Stock Market
IPOBreakingH.R. Hygiene Products IPO Lists Today on BSE SME; Modest Listing Gain Expected
H.R. Hygiene Products makes its debut on the BSE SME platform today, following an IPO that was subscribed 6.26 times. The grey market premium (GMP) suggests a small listing gain of around 1% over the upper issue price of ₹88.
IPOBreakingManipal Health Shares List at 11% Premium: Investors Book Gains on Market Debut
Manipal Health made a positive debut on the stock exchanges today, listing at a premium of over 11% against its issue price. The shares opened at ₹652 on the NSE and ₹655 on the BSE, rewarding successful allottees with immediate listing gains.
BreakingIRDAI Directs Insurers to Fast-Track Assam Flood Claims; Special Desks, Helplines Setup
India's insurance regulator, IRDAI, has instructed all insurance companies to expedite the settlement of flood claims for policyholders affected by the recent deluge in Assam. This directive mandates immediate deployment of surveyors, establishment of dedicated district-level claims desks, and 24x7 helplines to streamline the process. The move follows extensive flooding and heavy rainfall across Assam, which began on July 19.
Related Stories
IPOBreakingH.R. Hygiene Products IPO Lists Today on BSE SME; Modest Listing Gain Expected
H.R. Hygiene Products makes its debut on the BSE SME platform today, following an IPO that was subscribed 6.26 times. The grey market premium (GMP) suggests a small listing gain of around 1% over the upper issue price of ₹88.
IPOBreakingManipal Health Shares List at 11% Premium: Investors Book Gains on Market Debut
Manipal Health made a positive debut on the stock exchanges today, listing at a premium of over 11% against its issue price. The shares opened at ₹652 on the NSE and ₹655 on the BSE, rewarding successful allottees with immediate listing gains.
BreakingIRDAI Directs Insurers to Fast-Track Assam Flood Claims; Special Desks, Helplines Setup
India's insurance regulator, IRDAI, has instructed all insurance companies to expedite the settlement of flood claims for policyholders affected by the recent deluge in Assam. This directive mandates immediate deployment of surveyors, establishment of dedicated district-level claims desks, and 24x7 helplines to streamline the process. The move follows extensive flooding and heavy rainfall across Assam, which began on July 19.
BreakingIndian Microfinance Loans Dip 4% to ₹3.26 Lakh Crore by June End Amidst Monsoon Concerns
India's microfinance sector saw its loan portfolio contract by 4% to ₹3.26 lakh crore by the end of June. This first-quarter decline is primarily due to an uneven monsoon season, which has dampened rural demand and increased caution among lenders.